Trial intelligence / Profile preview

NITRITE-AMI

NCT01584453Phase 2Completed

Sponsor
Barts Health NHS Trust
Start
Apr 2012
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial infarction (MI) and reperfusion injury (IRI) comparing Sodium Nitrite with Placebo (2 arms). Primary endpoint: Infarct size measured by Creatine Kinase area under the curve at 48 hours. Started Apr 2012; status: completed.

02

Drugs

sodium nitrite
03

Conditions

myocardial infarction (MI)reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT01584453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01584453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call